Filing Details
- Accession Number:
- 0001209191-17-035187
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-05-24 21:14:44
- Reporting Period:
- 2017-05-22
- Filing Date:
- 2017-05-24
- Accepted Time:
- 2017-05-24 21:14:44
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1479290 | Revance Therapeutics Inc. | RVNC | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1225755 | P Lauren Silvernail | C/O Revance Therapeutics, Inc. 7555 Gateway Boulevard Newark CA 94560 | Cfo, Cbo & Secretary | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2017-05-22 | 1,793 | $20.20 | 36,566 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to an irrevocable sell to cover election previously adopted by Mrs. Silvernail.
- The shares were disposed to satisfy tax withholding obligations that arose in connection with the vesting of 4,667 shares of restricted stock on May 19, 2017.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.95 to $20.20. Mrs. Silvernail undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Billionaire Hedge Funds
